PharmChem (PharmChem) EBIT per Share : $0.06 (TTM As of Sep. 2023)

View and export this data going back to 2003. Start your Free Trial

What is PharmChem EBIT per Share?

PharmChem's EBIT per Share for the three months ended in Sep. 2023 was $0.06. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.06.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for PharmChem's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of PharmChem was 85.10% per year. The lowest was -48.20% per year. And the median was -8.55% per year.

PCHM's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 5.7
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

PharmChem's EBIT for the three months ended in Sep. 2023 was $0.30 Mil.

PharmChem EBIT per Share Historical Data

The historical data trend for PharmChem's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmChem EBIT per Share Chart

PharmChem Annual Data

Trend

Dec93

Dec94

Dec95

Dec96

Dec97

Dec98

Dec99

Dec00

Dec01

Dec02

EBIT per Share

Get a 7-Day Free Trial

0.20

0.46

0.13

-1.38

-0.13

PharmChem Quarterly Data
	Jun99	Sep99	Dec99	Mar00	Jun00	Sep00	Dec00	Mar01	Jun01	Sep01	Dec01	Mar02	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Sep22	Sep23
EBIT per Share	Get a 7-Day Free Trial															-0.10	-0.07	-0.05	0.06	0.06

PharmChem EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

PharmChem's EBIT per Share for the fiscal year that ended in Dec. 2002 is calculated as

	EBIT per Share		(A: Dec. 2002 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.783	/	5.853
=	-0.13

PharmChem's EBIT per Share for the quarter that ended in Sep. 2023 is calculated as

	EBIT per Share		(Q: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.303	/	5.021
=	0.06

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06

PharmChem (OTCPK:PCHM) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

PharmChem EBIT per Share Related Terms

Thank you for viewing the detailed overview of PharmChem's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmChem (PharmChem) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PharmChem Inc (OTCPK:PCHM) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

2411 E. Loop 820 N, Fort Worth, TX, USA, 76118

Website

https://www.pharmchek.com

PharmChem Inc is engaged in selling and distributing of the PharmChek Sweat Patch Device. PharmChek is a system that uses sweat to detect the presence of illegal drugs. It consists of a transparent polyurethane outer covering, a small absorbent pad, and a release liner. Geographically the activities are carried out throughout the United States.

Executives

Alto Investors Palo	10 percent owner	470 UNIVERSITY AVENUE, PALO ALTO CA 94301
Micro Cap Partners Lp	10 percent owner

PharmChem (PharmChem) Headlines

From GuruFocus

PharmChem (PCHM) Announces Response To Opposition

By PRNewswire PRNewswire • 08-11-2021